HomeNews

News

Over 21,500 Illegal Online Pharmacies Blocked in 2025 Following Roszdravnadzor

The Russian healthcare regulator has summarized the results of its internet monitoring efforts. Last year, Roszdravnadzor identified thousands of violators and referred the data...

Obesity Pill Battle: Lilly’s Chemistry vs. Novo’s Peptides

2026 marks not just the arrival of new therapies, but a fundamental shift in pharmaceutical manufacturing supply chains. The commercialization of oral obesity treatments...

OpenAI Enters Healthcare Market with ChatGPT Health and Enterprise Clinical Platform

OpenAI has officially announced its expansion into the healthcare sector with the launch of a dedicated product line. The company introduced the consumer-facing ChatGPT...

FEFU to Launch Russia’s First University-Based GMP Site for Biologics

Far Eastern Federal University (FEFU) has announced plans to establish a comprehensive infrastructure for the development and commercialization of biotech products.

Content Marketing in Pharma: How to Turn Production Capabilities into Reputational

The days of "silence" in B2B pharma are over. A decade ago, manufacturing plants could operate quietly for years, relying solely on the personal networks of their commercial directors. Today, such a strategy is a brake on growth.

FMBA Files for Registration of “Allergarda,” a Recombinant Vaccine for Birch Pollen Allergy

The vaccine is currently in Phase III clinical trials, evaluating its efficacy against a placebo in patients with allergic rhinitis.
spot_img

Expert Articles

spot_img